stay tuned:
elixi news from the
world

We are a Swiss pharmaceutical wholesaler, specialized in sourcing and delivering pharma products, medical devices and drugs from and to all over the world.

Lumakras (sotorasib), first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C

1 Giugno 2021

The FDA has approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of

[ More ]

Tagrisso (osimertinib) , First Adjuvant Therapy for Most Common Type of Lung Cancer

19 Dicembre 2020

The U.S. Food and Drug Administration has approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have

[ More ]